Top

Published in:

Open Access 01-12-2014 | Review

Emerging topics in FXTAS

Authors: Deborah A Hall, Rachael C Birch, Mathieu Anheim, Aia E Jønch, Elizabeth Pintado, Joanne O’Keefe, Julian N Trollor, Glenn T Stebbins, Randi J Hagerman, Stanley Fahn, Elizabeth Berry-Kravis, Maureen A Leehey

Published in: Journal of Neurodevelopmental Disorders | Issue 1/2014

Abstract

This paper summarizes key emerging issues in fragile X-associated tremor/ataxia syndrome (FXTAS) as presented at the First International Conference on the FMR1 Premutation: Basic Mechanisms & Clinical Involvement in 2013.

Available only for authorised users

Hagerman RJ, Leehey MA, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ: Intention tremor, parkinsonism, and generalized brain atrophy in older male carriers of fragile X. Neurology. 2001, 57: 127-130. 10.1212/WNL.57.1.127.PubMedCrossRef

Leehey M, Hagerman RJ, Landau WM, Grigsby J, Tassone F, Hagerman PJ: Tremor/ataxia syndrome in fragile X carrier males. Mov Disord. 2002, 17 (4): 744-745. 10.1002/mds.10208.CrossRef

Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, Berry-Kravis E, Brown WT, Schaeffer S, Kissel J, Tassone F, Hagerman PJ: Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Med Genet. 2003, 72 (4): 869-878.

Apartis E, Blancher A, Meissner WG, Guyant-Marechal L, Maltete D, De Broucker T, Legrand AP, Bouzenada H, Thanh HT, Sallansonnet-Froment M, Wang A, Tison F, Roue-Jagot C, Sedel F, Charles P, Whalen S, Heron D, Thobois S, Poisson A, Lesca G, Ouvard-Hernandez AM, Fraix V, Palfi S, Habert MO, Gaymard B, Dussaule JC, Pollak P, Vidaihet M, Durr A, Barbot JC: FXTAS: new insights and the need for revised diagnostic criteria. Neurology. 2012, 79 (18): 1898-1907. 10.1212/WNL.0b013e318271f7ff.PubMedCrossRef

Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A, Trapp BD, Iwahashi C, Brunberg J, Grigsby J, Hessl D, Becker EJ, Papazian J, Leehey MA, Hagerman RJ, Hagerman PJ: Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain. 2006, 129 (Pt 1): 243-255.PubMed

Hagerman RJ, Leavitt BR, Farzin F, Jacquemont S, Greco CM, Brunberg JA, Tassone F, Hessl D, Harris SW, Zhang L, Jardini T, Gane LW, Ferranti J, Ruiz L, Leehey MA, Grigsby J, Hagerman PJ: Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet. 2004, 74 (5): 1051-1056. 10.1086/420700.PubMedPubMedCentralCrossRef

Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, Gane LW, Grigsby J, Bourgeois JA, Finucane B, Jacquemont S, Brunberg JA, Zhang L, Lin J, Tassone F, Hagerman PJ, Hagerman RJ, Leehey MA: Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord. 2007, 22 (14): 2018-2030. 10.1002/mds.21493.PubMedCrossRef

Juncos J, Lazarus J, Graves-Allen E, Shubeck L, Rusin M, Novak G, Hamilton D, Rohr J, Sherman SL: New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS). Neurogenetics. 2011, 12 (2): 1-13.CrossRef

Seixas AI, Vale J, Jorge P, Marques I, Santos R, Alonso I, Fortuna AM, Pinto-Basto J, Coutinho P, Margolis RL, Sequeiros J, Silveria I: FXTAS is rare among Portuguese patients with movement disorders: FMR1 premutations may be associated with a wider spectrum of phenotypes. Behav Brain Funct. 2011, 7: 19. 10.1186/1744-9081-7-19.PubMedPubMedCentralCrossRef

10.

Hagerman R, Hagerman P: Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol. 2013, 12 (8): 786-798. 10.1016/S1474-4422(13)70125-X.PubMedPubMedCentralCrossRef

11.

Poston KL, McGovern RA, Goldman JS, Caccappolo E, Mazzoni P: Fragile X-associated tremor/ataxia syndrome (FXTAS) with myoclonus. Mov Disord. 2010, 25 (4): 514-516. 10.1002/mds.22929.PubMedCrossRef

12.

Grigsby J, Brega AG, Leehey MA, Goodrich GK, Jacquemont S, Loesch DZ, Cogswell JB, Epstein J, Wilson R, Jardini T, Gould E, Bennett RE, Hessl D, Cohen S, Cook K, Tassone F, Hagerman PJ, Hagerman RJ: Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome. Mov Disord. 2007, 22 (5): 645-650. 10.1002/mds.21359.PubMedCrossRef

13.

Seritan AL, Nguyen DV, Farias ST, Hinton L, Grigsby J, Bourgeois JA, Hagerman RJ: Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer’s disease. Am J Med Genet B Neuropsychiatr Genet. 2008, 147B (7): 1138-1144. 10.1002/ajmg.b.30732.PubMedPubMedCentralCrossRef

14.

Pugliese P, Annesi G, Cutuli N, Arabia G, Nicoletti G, Annesi F, Tarantino P, Gambardella A, Valentino P, Zappia M, Quatrone A: The fragile X premutation presenting as postprandial hypotension. Neurology. 2004, 63 (11): 2188-2189.PubMedCrossRef

15.

Bourgeois JA, Seritan AL, Casillas EM, Hessl D, Schneider A, Yang Y, Kaur I, Cogswell JB, Nguyen DV, Hagerman RJ: Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. J Clin Psychiatry. 2011, 72 (2): 175-182. 10.4088/JCP.09m05407blu.PubMedPubMedCentralCrossRef

16.

Bacalman S, Farzin F, Bourgeois JA, Cogswell J, Goodlin-Jones BL, Gane LW, Grigsby J, Leehey MA, Tassone F, Hagerman RJ: Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: Newly described fronto-subcortical dementia. J Clin Psychiatry. 2006, 67 (1): 87-94. 10.4088/JCP.v67n0112.PubMedCrossRef

17.

Roberts JE, Bailey DB, Mankowski J, Ford A, Sideris J, Weisenfeld LA, Heath TM, Golden RN: Mood and anxiety disorders in females with the FMR1 premutation. Amer J Med Genet B:. 2009, 150B (1): 130-139. 10.1002/ajmg.b.30786.CrossRef

18.

Hamlin AA, Sukharev D, Campos L, Mu Y, Tassone F, Hessl D, Nguyen DV, Loesch D, Hagerman RJ: Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS). Amer J Med Genet Part A. 2012, 158A (6): 1304-1309. 10.1002/ajmg.a.35323.CrossRef

19.

Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J, Doerflinger M, Hagerman PJ, Hagerman RJ: Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A. 2008, 146A (8): 1009-1016. 10.1002/ajmg.a.32060.PubMedPubMedCentralCrossRef

20.

Hamlin A, Liu Y, Nguyen DV, Tassone F, Zhang L, Hagerman RJ: Sleep apnea in fragile X premutation carriers with and without FXTAS. Amer J Med Genet Part B. 2011, 156B (8): 923-928.CrossRef

21.

Hagerman RJ, Coffey SM, Maselli R, Soontarapornchai K, Brunberg JA, Leehey MA, Zhang L, Gane LW, Fenton-Farrell G, Tassone F, Hagerman PJ: Neuropathy as a presenting feature in fragile X-associated tremor/ataxia syndrome. Am J Med Genet A. 2007, 143A (19): 2256-2260. 10.1002/ajmg.a.31920.PubMedCrossRef

22.

Berry-Kravis E, Goetz CG, Leehey MA, Hagerman RJ, Zhang L, Li L, Nguyen D, Hall D, Tartaglia N, Cogswell J, TAssone F, Hagerman PJ: Neuropathic features in fragile X premutation carriers. Am J Med Genet A. 2007, 143 (1): 19-26.CrossRef

23.

Soontarapornchai K, Maselli R, Fenton-Farrell G, Tassone F, Hagerman PJ, Hessl D, Hagerman RJ: Abnormal nerve conduction features in fragile X premutation carriers. Arch Neurol. 2008, 65 (4): 495-498. 10.1001/archneur.65.4.495.PubMedPubMedCentralCrossRef

24.

Liu J, Koscielska KA, Cao Z, Hulsizer S, Grace N, Mitchell G, Nacey C, Githinji J, McGee J, Garcia-Arocena D, Hagerman RJ, Nolta J, Pessah IN, Hagerman PJ: Signaling defects in iPSC-derived fragile X premutation neurons. Hum Mol Genet. 2012, 21 (17): 3795-3805. 10.1093/hmg/dds207.PubMedPubMedCentralCrossRef

25.

Seritan AL, Nguyen D, Mu Y, Tassone F, Bourgeois JA, Schneider A, Cogswell JB, Cook KR, Leehey MA, Grigsby J, Olichney JM, Adams PE, Legg W, Zhang L, Hagerman PJ, Hagerman RJ: Memantine for fragile X-associated tremor/ataxia syndrome (FXTAS): a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2013, 75 (3): 264-271.CrossRef

26.

Yang J, Niu YQ, Simon C, Chen L, Seritan AL, Schneider A: Effects of Memantine on Language/memory-related Brain Potentials in Fragile X-Associated Tremor/ataxia Syndrome (FXTAS), 1st International Conference on the FMR1 Premutation: Basic Mechanisms & Clinical Involvement. 2013, Perugia: Italy

27.

Leehey M, Hagerman P, Fragile X-associated tremor/ataxia syndrome (FXTAS): Fragile X-associated tremor/ataxia syndrome (FXTAS). Handbook of Clinical Neurology. Edited by: Subramoney S, Durr A. 2006, Amsterdam, New York: Elsevier, 373-386.

28.

Hall DA, Berry-Kravis E, Jacquemont S, Rice CD, Cogswell J, Zhang L: Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). Neurology. 2005, 65 (2): 299-301. 10.1212/01.wnl.0000168900.86323.9c.PubMedCrossRef

29.

Leehey MA, Legg W, Tassone F, Hagerman R: Fibromyalgia in fragile X mental retardation 1 gene premutation carriers. Rheumatology. 2011, 50 (12): 2233-2236. 10.1093/rheumatology/ker273.PubMedPubMedCentralCrossRef

30.

Brunberg JA, Jacquemont S, Hagerman RJ, Berry-Kravis EM, Grigsby J, Leehey MA, Tassone F, Brown WT, Greco CM, Hagerman PJ: Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. Am J Neuroradiol. 2002, 23 (10): 1757-1766.PubMed

31.

Adams PE, Adams JS, Nguyen DV, Hessl D, Brunberg JA, Tassone F, Zhang W, Koldewyn K, Rivera SM, Grigsby J, Zhang L, DeCarli C, Hagerman PJ, Hagerman RJ: Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. Am J Med Genet B Neuropsychiatr Genet. 2009, 153B (3): 775-785.

32.

Hall D, Tassone F, Klepitskaya O, Leehey M: Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers. Mov Disord. 2012, 27 (2): 296-300.PubMedPubMedCentralCrossRef

33.

Liu Y, Winarni TI, Zhang L, Tassone F, Hagerman RJ: Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers. Clin Genet. 2013, 84 (1): 74-77. 10.1111/cge.12026.PubMedCrossRef

34.

Loesch D, Sherwell S, Kinsella G, Tassone F, Taylor A, Amor D, Sung S, Evans A: Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene. Clin Genet. 2012, 82 (1): 88-92. 10.1111/j.1399-0004.2011.01675.x.PubMedCrossRef

35.

Kenneson A, Zhang F, Hagedorn CH, Warren ST: Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet. 2001, 10 (14): 1449-1454. 10.1093/hmg/10.14.1449.PubMedCrossRef

36.

Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ: Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet. 2000, 66 (1): 6-15. 10.1086/302720.PubMedPubMedCentralCrossRef

37.

Tassone F, Hagerman RJ, Loesch DZ, Lachiewicz A, Taylor AK, Hagerman PJ: Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet. 2000, 94 (3): 232-236. 10.1002/1096-8628(20000918)94:3<232::AID-AJMG9>3.0.CO;2-H.PubMedCrossRef

38.

Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ: Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA. 2004, 291 (4): 460-469. 10.1001/jama.291.4.460.PubMedCrossRef

39.

Chonchaiya W, Nguyen DV, Au J, Campos L, Berry-Kravis EM, Lohse K, Mu Y, Utari A, Hervey C, Wang L, Sorensen P, Cook K, Gane L, Tassone F, Hagerman RJ: Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome. Clin Genet. 2010, 78 (1): 38-46. 10.1111/j.1399-0004.2010.01448.x.PubMedPubMedCentralCrossRef

40.

Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, Xuncla M, Badenas C, Kulisevsky J, Gomez B, Mila M: Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet. 2009, 17 (10): 1359-1362. 10.1038/ejhg.2009.51.PubMedPubMedCentralCrossRef

41.

Winarni TI, Chonchaiya W, Sumekar TA, Ashwood P, Morales GM, Tassone F, Nguyen DV, Faradz SM, Van de Water J, Cook K, Hamlin A, Mu Y, Hagerman PJ, Hagerman RJ: Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A. 2012, 158A (10): 2473-2481. 10.1002/ajmg.a.35569.PubMedCrossRef

42.

Adams JS, Adams PE, Nguyen D, Brunberg JA, Tassone F, Zhang W, Koldewyn K, Rivera SM, Grigsby J, Zhang L, DeCarli C, Hagerman PJ, Hagerman RJ: Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS). Neurology. 2007, 69 (9): 851-859. 10.1212/01.wnl.0000269781.10417.7b.PubMedCrossRef

43.

Tassone F, Greco CM, Hunsaker MR, Seritan AL, Berman RF, Gane LW, Jacquemont S, Basuta K, Jin LW, Hagerman PJ, Hagerman RJ: Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav. 2012, 11 (5): 577-585. 10.1111/j.1601-183X.2012.00779.x.PubMedPubMedCentralCrossRef

44.

Greco CM, Tassone F, Garcia-Arocena D, Tartaglia N, Coffey SM, Vartanian TK, Brunberg JA, Hagerman PJ, Hagerman RJ: Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis. Arch Neurol. 2008, 65 (8): 1114-1116.PubMedPubMedCentralCrossRef

45.

Zhang L, Coffey S, Lua LL, Greco CM, Schafer JA, Brunberg J, Borodyanskaya M, Agius MA, Apperson M, Leehey M, Tartaglia N, Tassone F, Hagerman PJ, Hagerman RJ: FMR1 premutation in females diagnosed with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009, 80 (7): 812-814. 10.1136/jnnp.2008.160960.PubMedCrossRef

46.

Sullivan SD, Welt C, Sherman S: FMR1 and the continuum of primary ovarian insufficiency. Semin Reprod Med. 2011, 29 (4): 299-307. 10.1055/s-0031-1280915.PubMedCrossRef

47.

Bourgeois JA, Cogswell JB, Hessl D, Zhang L, Ono MY, Tassone F, Farzin F, Brunberg JA, Grigsby J, Hagerman RJ: Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome. Gen Hosp Psychiatry. 2007, 29 (4): 349-356. 10.1016/j.genhosppsych.2007.03.003.PubMedPubMedCentralCrossRef

48.

Hashimoto R, Javan AK, Tassone F, Hagerman RJ, Rivera SM: A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome. Brain. 2011, 134 (3): 863-878. 10.1093/brain/awq368.PubMedPubMedCentralCrossRef

49.

Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, Barbato I, Rice C, Gould E, Hall DA, Grigsby J, Wegelin JA, Harris S, Lewin F, Weinberg D, Hagerman PJ, Hagerman RJ: Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet. 2005, 139B (1): 115-121. 10.1002/ajmg.b.30241.PubMedCrossRef

50.

Grigsby J, Brega AG, Engle K, Leehey MA, Hagerman RJ, Tassone F, Hessl D, Hagerman PJ, Cogswell JB, Bennett RE, Cook K, Hall DA, Bounds LS, Paulich MJ, Reynold A: Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology. 2008, 22 (1): 48-60.PubMedCrossRef

51.

Sevin M, Kutalik Z, Bergman S, Vercelletto M, Renou P, Lamy E, Vingerhoets FJ, Di Virgilio G, Boisseau P, Bezieau S, Pasquier L, Rival JM, Beckmann JS, Damier P, Jacquemont S: Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation. J Med Genet. 2009, 46 (12): 818-824. 10.1136/jmg.2008.065953.PubMedCrossRef

52.

Leehey M, Berry-Kravis E, Goetz C, Zhang L, Hall D, Li L, Rice CD, Lara R, Cogswell J, Reynolds A, Gane L, Jacquemont S, Tassone F, Grigsby J, Hagerman RJ, Hagerman PJ: FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology. 2008, 70 (16): 139-142.

53.

Cohen S, Masyn K, Adams J, Hessl D, Rivera S, Tassone F, Brunberg J, DeCarli C, Zhang L, Cogswell J, Loesch D, Leehey M, Grigsby J, Hagerman PJ, Hagerman RJ: Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology. 2006, 67 (8): 1426-1431. 10.1212/01.wnl.0000239837.57475.3a.PubMedCrossRef

54.

Cornish KM, Li L, Kogan CS, Jacquemont S, Turk J, Dalton A, Hagerman RJ, Hagerman PJ: Age-dependent cognitive changes in carriers of the fragile X syndrome. Cortex; a journal devoted to the study of the nervous system and behavior. 2008, 44 (6): 628-636. 10.1016/j.cortex.2006.11.002.PubMedCrossRef

55.

Grigsby J, Brega AG, Jacquemont S, Loesch DZ, Leehey MA, Goodrich GK, Hagerman RJ, Epstein J, Wilson R, Cogswell JB, Jardini T, Tassone F, Hagerman PJ: Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). J Neurol Sci. 2006, 248 (1–2): 227-233.PubMedCrossRef

56.

Hashimoto R, Backer KC, Tassone F, Hagerman RJ, Rivera SM: An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS). J Psychiatr Res. 2011, 45 (1): 36-43. 10.1016/j.jpsychires.2010.04.030.PubMedPubMedCentralCrossRef

57.

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 2013, Arlington, VA: American Psychiatric Association, 5

58.

Mothersead PK, Conrad K, Hagerman RJ, Greco CM, Hessl D, Tassone F: An atypical progressive dementia in a male carrier of the fragile X premutation: An example of fragile X-associated tremor/ataxia syndrome. Appl Neuropsychol. 2005, 12 (3): 169-178. 10.1207/S15324826AN1203_7.PubMedCrossRef

59.

Burn DJ, Rowan EN, Allan LM, Molloy S, O’Brien JT, McKeith IG: Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006, 77 (5): 585-589. 10.1136/jnnp.2005.081711.PubMedPubMedCentralCrossRef

60.

Fahn S, Tolosa E, Marin C: Clinical Rating Scale for Tremor. Parkinson’s Disease and Movement Disorders. Edited by: Jankovic J, Tolosa E. 1987, Baltimore: Urban & Schwartzenberg, 225-234.

61.

Trouillas P, Takayanagi T, Hallett M, Currier R, Subramony S, Wessel K, Bryer A, Diener HC, Hassaquoi S, Gomez CM, Coutinho P, Ben Hamida M, Campanella G, Filla A, Schut L, Timann D, Honnorat J, Nighoghossian N, Manyam B: International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci. 1997, 145: 205-211. 10.1016/S0022-510X(96)00231-6.PubMedCrossRef

62.

Fahn S, Elton R, Committee MotUD: Unified Parkinson’s Disease Rating Scale. Recent Developments in Parkinson’s Disease. Edited by: Fahn S, Marsden C, Calne D, Goldstein M. 1987, Florhan Park: Macmillan Health Care Information, 153-164.

63.

O’Keefe JA, Dunn EJ, Berry-Kravis EM, Ouyang B, Hall DA: Characterization of balance deficits in FMR1 premutation carriers with and without FXTAS reveals a unique sensory profile of impaired vestibular control and postural stability. 2012, American Academy of Neurology: New Orleans

64.

Lipton SA: Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov. 2006, 5 (2): 160-170. 10.1038/nrd1958.PubMedCrossRef

65.

Ortigas MC, Bourgeois JA, Schneider A, Olichney J, Nguyen DV, Cogswell JB, Hall DA, Hagerman RJ: Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine. J Clin Psychopharmacol. 2010, 30 (5): 642-644.PubMedPubMedCentralCrossRef

66.

Cao Z, Hulsizer S, Tassone F, Tang HT, Hagerman RJ, Rogawski MA, Hagerman PJ, Pessah IN: Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum Mol Genet. 2012, 21 (13): 2923-2935. 10.1093/hmg/dds118.PubMedPubMedCentralCrossRef

Title: Emerging topics in FXTAS
Authors: Deborah A Hall
Rachael C Birch
Mathieu Anheim
Aia E Jønch
Elizabeth Pintado
Joanne O’Keefe
Julian N Trollor
Glenn T Stebbins
Randi J Hagerman
Stanley Fahn
Elizabeth Berry-Kravis
Maureen A Leehey
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Journal of Neurodevelopmental Disorders / Issue 1/2014
Print ISSN: 1866-1947
Electronic ISSN: 1866-1955
DOI: https://doi.org/10.1186/1866-1955-6-31

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Emerging topics in FXTAS

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy (1H MRS)

Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring

Pre-pulse inhibition and antisaccade performance indicate impaired attention modulation of cognitive inhibition in 22q11.2 deletion syndrome (22q11DS)

Reactivity to fearful expressions of familiar and unfamiliar people in children with autism: an eye-tracking pupillometry study

Associated features in females with an FMR1 premutation

Improving IQ measurement in intellectual disabilities using true deviation from population norms